# Response to Medication Registry

> **NCT02593916** · — · COMPLETED · sponsor: **Intermountain Health Care, Inc.** · enrollment: 196 (actual)

## Conditions studied

- Adverse Drug Events

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02593916
- **Lead sponsor:** Intermountain Health Care, Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2018-09
- **Final completion:** 2018-12
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2019-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02593916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02593916, "Response to Medication Registry". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02593916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*